Novartis failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' ...

Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop ...

Pacira BioSciences PCRX announced the reception of the ‘940 patent from the U.S. Patent and Trademark Office that protects ...

The Chinese pharmaceutical industry has a reputation abroad as a supplier of active pharmaceutical ingredients invented ...

Analyst evaluates Teva's stock performance and recommends holding due to revenue growth and successful debt reduction efforts ...

As growers worldwide navigate the challenges of the coming year, these factors are impacting their decisions the most.

The differences between the generics industry and other pharma companies wouldn’t exist without patents – legal titles that exclude others from producing or using an invention or innovation ...

arguing that four out of 10 products covered by the scheme are actually branded generics or biosimilars, but was prevented from doing so by a High Court ruling. Samuels said today that the BGMA ...

Panelists proposed policy solutions to ensure long-term sustainability of infused biosimilars amid current challenges, ...

A ready-to-use premixed formulation of Adrenalin (epinephrine in 0.9% sodium chloride injection) has been made available by Endo, Inc.